Intraocular cell-based production of glucagon-like peptide-1 in the anterior chamber

Acta Ophthalmologica

Volumn 88, Issue 8, 2010, Pages

  Zhang, Rong ^a   Ma, Ke ^a   Xu, Liang ^a   Wallrapp, Christine ^b   Jonas, Jost B ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CellMed AG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; GLUCAGON LIKE PEPTIDE 1; PLASMID DNA;

ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; CELL THERAPY; CELL TRANSFER; CRYOPRESERVATION; ENCAPSULATION; EXPERIMENTAL RABBIT; GENETIC TRANSFECTION; HUMAN; LETTER; MESENCHYME CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; STROMA CELL;

EID: 78649811366     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01762.x     Document Type: Letter

References (5)

1. During MJ, Cao L, Zuzga DS, et al. (2003): Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 9: 1173-1179.
2. Jonas JB, (2005): Intravitreal triamcinolone acetonide for treatment of intraocular edematous and neovascular diseases. Acta Ophthalmol 83: 645-663.
3. Lee M, Lo AC, Cheung PT, Wong D, &, Chan BP, (2009): Drug carrier systems based on collagen-alginate composite structures for improving the performance of GDNF-secreting HEK293 cells. Biomaterials 30: 1214-1221.
4. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, & MARINA Study Group (2006): Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355: 1419-1431.
5. Tao W, Wen R, Goddard MB, et al. (2002): Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 43: 3292-3298.